Rentokil Initial (NYSE:RTO) Upgraded by Sanford C. Bernstein to Outperform Rating

Key Points

• Rentokil Initial was upgraded from an "underperform" rating to an "outperform" rating by Sanford C. Bernstein.
• The current consensus rating for Rentokil Initial is "Moderate Buy," with various analysts giving ratings ranging from Strong Buy to Sell.
• As of the latest trading, Rentokil Initial's stock price reached $27.49, with a market capitalization of $13.89 billion and a P/E ratio of 18.20.

Rentokil Initial (NYSE:RTO - Get Free Report) was upgraded by stock analysts at Sanford C. Bernstein from an "underperform" rating to an "outperform" rating in a report issued on Tuesday, Marketbeat Ratings reports.

A number of other analysts also recently issued reports on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Rentokil Initial in a report on Saturday, September 27th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Rentokil Initial in a research report on Monday, July 21st. Finally, Berenberg Bank upgraded shares of Rentokil Initial to a "strong sell" rating in a report on Monday, September 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Rentokil Initial currently has a consensus rating of "Moderate Buy".

Rentokil Initial Stock Performance

Rentokil Initial stock traded up $0.92 during mid-day trading on Tuesday, reaching $27.49. The company's stock had a trading volume of 149,342 shares, compared to its average volume of 782,258. Rentokil Initial has a 12-month low of $19.60 and a 12-month high of $27.55. The company has a market capitalization of $13.89 billion, a P/E ratio of 18.20, a PEG ratio of 4.60 and a beta of 0.95. The firm's fifty day moving average price is $24.72 and its two-hundred day moving average price is $23.77.

Hedge Funds Weigh In On Rentokil Initial

A number of large investors have recently made changes to their positions in RTO. GAMMA Investing LLC lifted its holdings in Rentokil Initial by 996.0% during the 1st quarter. GAMMA Investing LLC now owns 9,206 shares of the company's stock valued at $211,000 after buying an additional 8,366 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of Rentokil Initial by 35.7% in the 1st quarter. Park Avenue Securities LLC now owns 11,653 shares of the company's stock worth $267,000 after buying an additional 3,063 shares during the last quarter. Pullen Investment Management LLC purchased a new position in shares of Rentokil Initial in the 1st quarter worth approximately $1,114,000. Cambridge Investment Research Advisors Inc. grew its position in shares of Rentokil Initial by 44.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,930 shares of the company's stock worth $296,000 after buying an additional 3,993 shares during the last quarter. Finally, Keystone Financial Services grew its position in shares of Rentokil Initial by 22.0% in the 1st quarter. Keystone Financial Services now owns 11,392 shares of the company's stock worth $261,000 after buying an additional 2,057 shares during the last quarter. 9.91% of the stock is owned by hedge funds and other institutional investors.

Rentokil Initial Company Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.